RITEDOSE

Live / Registered — Registered (as of 13 Feb 2024)

What this means for you

Registered since 13 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97124132
Registration number
7305546
Mark type
Stylized text
Filed
14 Nov 2021
Published for opposition
12 Jul 2022
Registered
13 Feb 2024

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections, neurological problems, insomnia, hair loss, immunologic ailments; Pharmaceutical oral liquid preparations in the nature of analgesics for pain management; Pharmaceutical oral liquid preparations in the nature of oral contraceptives; Blow fill seal containers for medical use sold filled with pharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections, neurological problems, insomnia, hair loss, immunologic ailments
  • Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals to the order and specification of others. Repackaging services for others in the field of pharmaceuticals and other preparations for medical or veterinary purposes; Providing contract development and manufacturing organization (CDMO) services, namely, by providing contract manufacturing of pharmaceuticals for specific companies

Owner

Prosecution history

  • 01 Jan 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
  • 13 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 13 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
  • 09 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 08 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 08 Jan 2024 — EXAMINER'S AMENDMENT ENTERED
  • 08 Jan 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 08 Jan 2024 — EXAMINERS AMENDMENT E-MAILED
  • 08 Jan 2024 — SU-EXAMINER'S AMENDMENT WRITTEN
  • 12 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 11 Dec 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 11 Dec 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 01 Dec 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 01 Dec 2023 — NON-FINAL ACTION E-MAILED
  • 01 Dec 2023 — SU - NON-FINAL ACTION - WRITTEN

View this trademark record on Marksy